Literature DB >> 26585492

Prolactin-Induced Protein regulates cell adhesion in breast cancer.

Marion Vanneste1, Ali Naderi2.   

Abstract

Prolactin-Induced Prolactin (PIP) is widely expressed in breast cancer and has key cellular functions in this disease that include promoting invasion and cell cycle progression. Notably, we have recently identified a strong association between PIP-binding partners and a number of cell functions that are involved in cell adhesion. Therefore in this study, we investigated the effect of PIP on the regulation of cell adhesion using PIP-silencing in breast cancer cell lines T-47D, BT-474, and MFM-223. Our findings suggest that PIP expression is necessary for cell adhesion in a process that shows variation in the pattern of PIP regulation of cell-matrix and cell-cell adhesions based on the types of adhesion surface and breast cancer cell line. In this respect, we observed that PIP-silencing markedly reduced cell adhesion to uncoated plates in all three cell lines. In addition, in T-47D and MFM-223 cells fibronectin matrix induced baseline adhesion and reversed the PIP-silencing mediated reduction of cell adhesion. However, in BT-474 cells we did not observe an induction of baseline adhesion by fibronectin and PIP-silencing led to a marked reduction in cell adhesion to both uncoated and fibronectin-coated plates. Furthermore, we observed a significant reduction in cell-cell adhesion of BT-474 cell line following PIP-silencing. To explain an underlying mechanism for PIP regulation of cell adhesion, we found that PIP expression is necessary for the formation of α-actinin/actin-rich podosomes at the adhesion-sites of breast cancer cells. In summary, this study suggests that PIP expression regulates the process of cell adhesion in breast cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cell adhesion; Prolactin-Induced Protein

Mesh:

Substances:

Year:  2015        PMID: 26585492     DOI: 10.1016/j.bbrc.2015.11.043

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.

Authors:  Anton Pottegård; Timothy L Lash; Deirdre Cronin-Fenton; Thomas P Ahern; Per Damkier
Journal:  Br J Clin Pharmacol       Date:  2018-07-08       Impact factor: 4.335

2.  Prolactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients.

Authors:  Karolina Jablonska; Jedrzej Grzegrzolka; Marzenna Podhorska-Okolow; Mariusz Stasiolek; Bartosz Pula; Mateusz Olbromski; Agnieszka Gomulkiewicz; Aleksandra Piotrowska; Janusz Rys; Aleksandra Ambicka; Siew Hwa Ong; Maciej Zabel; Piotr Dziegiel
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

3.  Analyses of key mRNAs and lncRNAs for different osteo-differentiation potentials of periodontal ligament stem cell and gingival mesenchymal stem cell.

Authors:  Linglu Jia; Yunpeng Zhang; Dongfang Li; Wenjing Zhang; Dongjiao Zhang; Xin Xu
Journal:  J Cell Mol Med       Date:  2021-05-24       Impact factor: 5.310

4.  Suppression of OSCC malignancy by oral glands derived-PIP identified by iTRAQ combined with 2D LC-MS/MS.

Authors:  Qibo Wang; Yuan Zhi; Wenhao Ren; Shaoming Li; Zhichao Dou; Xiaoming Xing; Xinyu Quan; Yuting Wang; Chunmiao Jiang; Xiao Liang; Ling Gao; Keqian Zhi
Journal:  J Cell Physiol       Date:  2019-01-28       Impact factor: 6.384

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.